PharmaLinkAdmin

LARGO, Fla., May 30, 2025 (Newswire.com) – PharmaLink, a leader in pharmaceutical reverse distribution and returns management, today unveiled plans for a more than 50,000-square-foot expansion of its flagship operations center that will bring the overall total square footage of the facility to 150,000 square feet. The new space, scheduled to open in June 2025, […]

[Largo, FL] — PharmaLink Inc., a national leader in pharmaceutical reverse distribution, and Recall Results, a prominent provider of comprehensive recall management and support services, today announced a strategic partnership aimed at enhancing drug safety and recall efficiency in the pharmaceutical industry. This groundbreaking collaboration leverages PharmaLink Inc.’s expertise in pharmaceutical returns processing and Recall

(LARGO, FL) PharmaLink, Inc., an Industry-leading pharmaceutical reverse distributor, announced today a new contract relationship with biopharmaceutical manufacturer Merck Sharp & Dohme LLC (Merck). The new Returns Processing Service Agreement is expected to enhance the returns process for downstream customers while maintaining the integrity of supply chain security.

(LARGO, FL) PharmaLink, Inc., a leading pharmaceutical reverse distributor, announced today its acquisition of Cybornetic Systems, Inc. dba PharmaReturns, Inc. In addition to expanding its national account base with top tier clients, the purchase provides PharmaLink with an innovative technology platform for returns processing that adds Artificial Intelligence (AI) and new levels of customization to the reverse distribution process for pharmaceutical manufacturers. The Internet Managed Product Returns Solution (IMPRS) currently supports returns processing operations for over 400 Pharmaceutical manufacturers in the United States.

Largo, FL. – February 2023- Industry leading pharmaceutical returns management company, PharmaLink, Inc. announced today that it has completed its second expansion of its current headquarters and processing location in Largo, Florida. The expansion increases its overall capacity to 91,000 square feet at its current facility and will substantially augment its processing and product storage capacity.

September 2, 2021 – PharmaLink, Inc., an industry-leading pharmaceutical reverse distributor, is proud to announce a new contract relationship with biopharmaceutical manufacturer Amgen. The new Returns Processing and Recall Management service agreement enhances the returns process for downstream customers while maintaining the integrity of supply chain security.